Alliance Global Partners

Vivos Therapeutics, Inc. is a medical technology company based in Highlands Ranch, Colorado, focused on developing and commercializing innovative solutions for patients suffering from sleep disordered breathing, particularly mild to moderate obstructive sleep apnea (OSA). The company's flagship offering, the Vivos System, provides a non-surgical, non-invasive, and cost-effective treatment that utilizes customized oral appliances and specialized treatment protocols to modify the size, shape, and position of airway tissues. This approach aims to open airway space and alleviate symptoms associated with OSA. Vivos Therapeutics also supports its network of healthcare providers, including general dentists and medical professionals, by offering training and access to its technology. Additionally, the company licenses its intellectual property to third-party manufacturers for the production of appliance devices. Established in 2007, Vivos Therapeutics has positioned itself as a leader in addressing sleep disordered breathing in the United States and Canada.

Genprex, Inc. is a clinical-stage gene therapy company based in Austin, Texas, focused on developing innovative therapies for cancer and diabetes. The company's proprietary technology platform utilizes a non-viral delivery system to encapsulate cancer-fighting genes in nanoscale hollow spheres known as nanovesicles. These nanovesicles are administered intravenously, allowing tumor cells to absorb the genes, which can then correct deficiencies in protein expression. Genprex's lead product candidate, Oncoprex immunogene therapy, targets non-small cell lung cancer (NSCLC) by disrupting cancer cell signaling pathways, promoting programmed cell death, and enhancing the immune response against tumors. Additionally, Oncoprex addresses mechanisms that contribute to drug resistance. Genprex collaborates with leading institutions to advance its pipeline of gene therapies, aiming to provide new treatment options for patients with limited alternatives.

HEXO Corp is a consumer packaged goods cannabis company that develops and distributes award-winning products for the global cannabis market. Utilizing a hub and spoke business strategy, HEXO partners with Fortune 500 companies to leverage its brand value, cannabinoid isolation technology, and regulatory expertise, enhancing the distribution capabilities of established firms. As one of the largest licensed cannabis companies in Canada, HEXO operates 1.8 million square feet of facilities in Ontario and Quebec, and is establishing a processing, production, and distribution center in Greece to expand its European presence. The company serves both the adult-use and medical cannabis markets in Canada.

Harvest Health & Recreation is a vertically integrated cannabis company dedicated to enhancing lives through medical marijuana. The company operates in three primary areas: cultivation, processing, and retail dispensaries, allowing it to manage the entire supply chain effectively. Harvest Health & Recreation offers a diverse range of products and resources to patients and consumers, ensuring access to quality medical cannabis. Additionally, the company is committed to supporting local communities through financial contributions, services, and volunteer efforts, reflecting its dedication to social responsibility alongside its business operations.